Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-858-4 | CAS number: 12037-47-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Silicon orthophosphate is highly water soluble (1085 mg/L at 20°C). It completely dissociates into silicon and phosphate ions after systemic uptake (relevant pH ranges 2 -7). The tetravalent silicon ion and the phosphate ion will then react with the media to form different silicon and phosphate species depending on the pH and redox potential of the media. The dissociated silicon ion exists in water predominantly as H4SiO4/Si(OH)4, which is also the main species when silicon dioxide is dissolved in water. Therefore the silicon component of silicon orthophosphate can be covered by data from the read-across substance silicon dioxide, whereas the phosphate component has been assessed based on publically available data summaries from a study performed in Korea (no access granted for REACH Registration). No data for reproductive toxicity is available for the target substance silicon orthophosphate however the data from silicon dioxide is considered to be the worst-case and as such is acceptable for use.
An one-generation study with silicon dioxide was performed (Leuschner, 1963). 5 female rats and 1 male rat per group were fed the test substance or the control diet for 6 months at concentrations of 497 (males) and 509 (females) mg/kg bw/day. The animals were mated on a 1:5 basis after 4 1/2 month for an overall period of 14 days. No clinical signs, mortality, abnormalities in body-weight gain, feed consumption and haematology were observed. Effects on fertility were not described in the study. Therefore, the overall NOAEL was determined to be 497 mg/kg bw day. In pups, no behavioural, developmental or structural abnormalities were seen.
A publically available summary of an OECD 422 study on dipotassium hydrogenorthophosphate showed that reproductive performance of treated animals was similar to control animals considering mating/parturition rate, mating/gestation period and male/female fertility as reproductive indices. Therefore, the NOAEL of dipotassium hydrogenorthophosphate for fertility of male and female rats was determined to be≥1000 mg/kg bw/day. As this study was performed in Korea suitable access was not granted for REACH registration and as such no robust summary for this study is included in the dossier but the results are mentioned here for completeness.
The worst-case value derived from the silicon dioxide study will be used for the purpose of hazard classification and risk assessment.
Short description of key information:
Oral (one-generation study, silicon dioxide), subchronic, rat: NOAEL males= ≥500 mg/kg bw/day
Justification for selection of Effect on fertility via oral route:
Hazard assessment is conducted by means of read-across from silicon dioxide.
Effects on developmental toxicity
Description of key information
Oral (OECD 414, silicon dioxide), mouse: NOAEL (developmental), males/females = ≥1340 mg/kg bw/day
Oral (OECD 414, silicon dioxide), rabbit: NOAEL (developmental), males/females = ≥1600 mg/kg bw/day
Oral (OECD 414, silicon dioxide), hamster: NOAEL (developmental), males/females = ≥1600 mg/kg bw/day
Oral (OECD 414, silicon dioxide), rat: NOAEL (developmental), males/females = ≥1350 mg/kg bw/day
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Silicon orthophosphate is highly water soluble (1085 mg/L at 20°C). It completely dissociates into silicon and phosphate ions after ingestion via the oral route (pH 2 -7). The tetravalent silicon ion and the phosphate ion will then react with the media to form different silicon and phosphate species depending on the pH and redox potential of the media. The dissociated silicon ion exists in water predominantly as H4SiO4/Si(OH)4, which is also the main species when silicon dioxide is dissolved in water. Therefore the silicon component of silicon orthophosphate can be covered by data from the read-across substance silicon dioxide, whereas the phosphate component has been assessed based on publically available data summaries from a study performed in Korea (no access granted for REACH Registration). No data for reproductive toxicity is available for the target substance silicon orthophosphate however the data from silicon dioxide is considered to be the worst-case and as such is acceptable for use.
Developmental toxicity of silicon dioxide was investigated by the FDA (1973) in rabbits, rats, mice and hamsters in studies performed equivalent to OECD 414. The animals (11 -26/group, depending on the species) were treated orally once a day with test substance concentrations between 13.4 and 1600 mg/kg bw/day during gestation. The administration of up to the highest doses tested had no clear discernible effect on nidation nor on maternal and fetal survival. The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differ from the number occurring spontaneously in the sham-treated controls. Therefore, the NOAELs for developmental toxicity were determined to be≥1600 mg/kg bw/day for rabbits and hamster,≥1340 mg/kg bw/day for mice and≥1350 mg/kg bw/day for rats.
For dipotassium hydrogenorthophosphate an OECD 422 combined repeated dose toxicity study with reproduction / developmental toxicity screening conducted under GLP conditions was performed in male and female Sprague-Dawley rats (Shim, 2005).
16 animals/sex were treated once daily by gavage with 1000 mg/kg bw of the substance dissolved in water. The negative control group animals received the vehicle. The females were treated 2 weeks before mating until day 4 after parturition (~54 days) and the males for 42 days. 6 animals/sex were considered in satellite groups during a post-exposure recovery period of 2 weeks post administration.
A publically available summary of an OECD 422 study on dipotassium hydrogenorthophosphate showed that in the parental animals, there were no effects of systemic and fertile toxicity observed which were considered to be treatment related. In the offspring of the treated animals, no signs for developmental toxicity were observed considering corpus lutea, implantation sites, pre/post-implantation loss, litter size, birth rates, body weights and gross pathology as indices. Therefore, the NOAEL of dipotassium hydrogenorthophosphate for developmental toxicity of male and female rats was determined to be≥1000 mg/kg bw/day.
As this study was performed in Korea suitable access was not granted for REACH registration and as such no robust summary for this study is included in the dossier but the results are mentioned here for completeness.
The worst-case value derived from the silicon dioxide study will be used for the purpose of hazard classification and risk assessment.
Justification for selection of Effect on developmental toxicity: via oral route:
Hazard assessment is conducted by means of read-across from silicon dioxide.
Justification for classification or non-classification
The available data on toxicity to reproduction of the test substance do not meet the criteria for classification according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and are therefore conclusive but not sufficient for classification.
No information is available on effects via lactation.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.